Condition category
Not Applicable
Date applied
05/01/2011
Date assigned
03/03/2011
Last edited
15/03/2011
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Mr Svein Barene

ORCID ID

Contact details

PO Box 1480
Bodø
8049
Norway
svein.barene@uin.no

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

N/A

Study information

Scientific title

Soccer and Zumba as health promoting activities among Norwegian hospital employees: a cluster randomised controlled intervention trial

Acronym

Study hypothesis

1. 12 weeks of soccer and Zumba training, respectively, increases the maximal oxygen uptake (VO2max) and fat oxidation during activity and decreases the systolic and diastolic blood pressure, total body fat mass, fasting insulin, glucose, sensitive C-reactive protein (CRP) and low density lipoprotein (LDL)-cholesterol in the blood compared to the control group
2. 12 weeks of soccer and Zumba training, respectively, increases total body muscle mass, the isometric strength in lower body, coordination (balance), jump height and flexibility in the hamstrings muscles and lower back compared to the control group
3. 12 weeks of soccer and Zumba training, respectively, decreases musculoskeletal pain, kinesiophobia and sickness absence compared to the control group
4. Inflammation, measured as cytokine synthesis in EDTA plasma, increases from before to after a single training session
5. 12 weeks of soccer an Zumba training, respectively, improves the work ability, the individual feeling of wellness and the interpersonal relations in the workplace among the participants compared to the control group
6. After 39 weeks, the maximum oxygen uptake (VO2max) and the total body muscle mass is higher in the soccer and the Zumba group, respectively, compared to the control group
7. In the time period from 12 to 39 weeks, fewer participants in the Zumba group have dropped out of the study compared to the participants from the soccer group

Ethics approval

Regional Committees for Medical and Health Research Ethics (REK), Norway approved on the 13th December 2010 (ref: 2010/2385-8)

Study design

Cluster randomised controlled intervention trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Hospitals

Trial type

Quality of life

Patient information sheet

Not available in web format, please use the contact details below to request a patient information sheet

Condition

Physical activity

Intervention

Participants are randomised in clusters related to their team at the workplace to receive one of the following for 12 weeks:
1. Soccer training: three weekly training sessions of 60 minutes duration offered to the participants
2. Zumba training: three weekly training sessions of 60 minutes duration offered to the participants
3. Control group: participate in the tests and questionnaires

Intervention type

Other

Phase

Not Applicable

Drug names

Primary outcome measures

Maximal oxygen uptake (VO2max), measured before the intervention (Timepoint 1: Jan 2011), after the intervention period (Timepoint 2: Mar/Apr 2011) and after 39 weeks (Timepoint 3: Sep/Oct 2011)

Secondary outcome measures

Measured before the intervention (Timepoint 1: Jan 2011), after the intervention period (Timepoint 2: Mar/Apr 2011) and after 39 weeks (Timepoint 3: Sep/Oct 2011):
1. Systolic and diastolic blood pressure
2. Total body muscle mass and fat mass
3. Inflammation, measured as cytokine synthesis in EDTA plasma
4. Physical capacity, isometric strength, coordination, jump height and flexibility
5. Musculoskeletal pain, kinesiophobia and sickness absence
6. Sensitive CRP and LDL-cholesterol, glucose, insulin

Overall trial start date

10/01/2011

Overall trial end date

31/12/2011

Reason abandoned

Eligibility

Participant inclusion criteria

1. Hospital employees
2. Aged 25 - 65 years, either sex

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

115

Participant exclusion criteria

1. Angina pectoris
2. Pregnancy
3. Life-threatening diseases

Recruitment start date

10/01/2011

Recruitment end date

31/12/2011

Locations

Countries of recruitment

Norway

Trial participating centre

PO Box 1480
Bodø
8049
Norway

Sponsor information

Organisation

Nordland Hospital Bodø (Norway)

Sponsor details

PO Box 1480
Bodø
8092
Norway
postmottak@nlsh.no

Sponsor type

Hospital/treatment centre

Website

http://www.nlsh.no/

Funders

Funder type

Hospital/treatment centre

Funder name

Nordland Hospital Bodø (Norway)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

University of Nordland, Bodø (Norway)

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

University of Copenhagen (Denmark)

Alternative name(s)

University of Copenhagen, KU

Funding Body Type

private sector organisation

Funding Body Subtype

academic

Location

Denmark

Funder name

Friskhuset Fitness Centre, Bodø

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Funder name

The municipality of Bodø

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

Publication citations

Additional files

Editorial Notes